These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Enalapril and Lisinopril in Renovascular Hypertension Antihypertensne and Hormonal Effects of Two New Angio-Tensin-Converting-Enzyme (ACE) Inhibitors. Karlberg BE, Fyhrquist F, Grönhagen-Riska C, Tikkanen I, Öhman KP. Scand J Urol Nephrol; 1984 Jul; 18(sup79):103-106. PubMed ID: 27786014 [Abstract] [Full Text] [Related]
3. Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension. Whelton A, Dunne B, Glazer N, Kostis JB, Miller WE, Rector DJ, Tresznewsky ON. J Hum Hypertens; 1992 Aug; 6(4):325-31. PubMed ID: 1331444 [Abstract] [Full Text] [Related]
4. Antihypertensive and hormonal effects of lisinopril, a new angiotensin converting enzyme (ACE) inhibitor in patients with renovascular hypertension. Karlberg BE, Rosenqvist U. Acta Med Scand Suppl; 1986 Aug; 714():33-42. PubMed ID: 3033998 [Abstract] [Full Text] [Related]
5. Enalapril and atenolol in primary hypertension--a comparative study of blood pressure lowering and hormonal effects. Ohman KP, Karlberg BE. Scand J Urol Nephrol Suppl; 1984 Aug; 79():93-7. PubMed ID: 6089325 [Abstract] [Full Text] [Related]
6. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension. Jackson B, Cubela R, Johnston CI. J Hypertens; 1984 Aug; 2(4):371-7. PubMed ID: 6099390 [Abstract] [Full Text] [Related]
7. Assessment of the antihypertensive effect of lisinopril using 24-hour ambulatory monitoring. Herpin D, Conte D. J Hum Hypertens; 1989 Jun; 3 Suppl 1():11-5. PubMed ID: 2550634 [Abstract] [Full Text] [Related]
8. Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension. Wallis EJ, Ramsay LE, Hettiarachchi J. Clin Pharmacol Ther; 1998 Oct; 64(4):439-49. PubMed ID: 9797801 [Abstract] [Full Text] [Related]
9. [Ambulatory monitoring of arterial pressure in the treatment of mild-moderate arterial hypertension with lisinopril vs. enalapril]. Motero Carrasco J. Arch Inst Cardiol Mex; 1997 Oct; 67(1):29-37. PubMed ID: 9221708 [Abstract] [Full Text] [Related]
10. Enalapril (MK421) in the treatment of hypertension with renal artery stenosis. Hodsman GP, Brown JJ, Cumming AM, Davies DL, East BW, Lever AF, Morton JJ, Murray GD, Robertson JI. J Hypertens Suppl; 1983 Oct; 1(1):109-17. PubMed ID: 6100599 [Abstract] [Full Text] [Related]
11. Initial evaluation of the non-sulfhydryl-containing converting enzyme inhibitor MK-521 in hypertensive humans. Rotmensch HH, Vincent M, Vlasses PH, Swanson BN, Irvin JD, Hichens M, Harris KE, Ferguson RK. Fed Proc; 1984 Apr; 43(5):1333-5. PubMed ID: 6323225 [Abstract] [Full Text] [Related]
12. Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial. Herrera-Arellano A, Miranda-Sánchez J, Avila-Castro P, Herrera-Alvarez S, Jiménez-Ferrer JE, Zamilpa A, Román-Ramos R, Ponce-Monter H, Tortoriello J. Planta Med; 2007 Jan; 73(1):6-12. PubMed ID: 17315307 [Abstract] [Full Text] [Related]
13. Correlation between angiotensin converting enzyme inhibition and the acute hypotensive response to MK 421 in essential hypertension. Jackson B, McGrath BP, Johnston CI. Clin Exp Pharmacol Physiol Suppl; 1982 Jan; 7():99-104. PubMed ID: 6291832 [Abstract] [Full Text] [Related]
14. Angiotensin-converting enzyme inhibitors in hypertension: a review. Salvetti A, Pedrinelli R, Arzilli F, Abdel-Haq B, Magagna A, Lucarini A, Graziadei L, Nuccorini A, Taddei S. Int J Clin Pharmacol Res; 1985 Jan; 5(6):429-38. PubMed ID: 3005182 [Abstract] [Full Text] [Related]
15. Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade. Biollaz J, Brunner HR, Gavras I, Waeber B, Gavras H. J Cardiovasc Pharmacol; 1982 Jan; 4(6):966-72. PubMed ID: 6185790 [Abstract] [Full Text] [Related]
16. A comparison of single doses of lisinopril and enalapril in hypertension. Dews I, Wiseman WT, al-Khawaja I, Stephens J, VandenBurg M. J Hum Hypertens; 1989 Jun; 3 Suppl 1():35-9. PubMed ID: 2550644 [Abstract] [Full Text] [Related]
17. [Multicenter clinical study of the antihypertensive activity of lisinopril]. Cinotti GA, Bossini A, Cagli V, Corea L, Di Veroli C, Morabito S, Pierucci A, Porcellati C, Savino K, Timio M. Minerva Med; 1989 Jan; 80(1):53-63. PubMed ID: 2536907 [Abstract] [Full Text] [Related]
18. Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril. Leenen FH, Myers MG, Joyner CD, Toal CB. Can J Cardiol; 2002 Dec; 18(12):1285-93. PubMed ID: 12518180 [Abstract] [Full Text] [Related]
19. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models. Nagata S, Takeyama K, Fukuya F, Nagai R, Hosoki K, Nishimura K, Deguchi T, Karasawa T. Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746 [Abstract] [Full Text] [Related]
20. Pharmacologic nephrectomy with chronic angiotensin converting enzyme inhibitor treatment in renovascular hypertension in the rat. Jackson B, Franze L, Sumithran E, Johnston CI. J Lab Clin Med; 1990 Jan; 115(1):21-7. PubMed ID: 2299253 [Abstract] [Full Text] [Related] Page: [Next] [New Search]